Sponsors

Lead Sponsor

University of Western Ontario, Canada

This study will evaluate the responsiveness central reader based EIs for assessing clinical disease activity. Endoscopic images will be obtained from recent large multicenter randomized clinical trial and assessed using utilizing CIMS readers using EIs (MMCS, UCEIS, MBS) and a VAS (visual analog scale). The primary efficacy endpoint of this trial was clinical and endoscopic remission at week 6, with a secondary endpoint of endoscopic and clinical remission at week 10. For the same subjects, clinical data will be obtained including a modified UCDAI (Ulcerative Colitis Disease Activity Index). Central readers are blinded to clinical scores.

Related studies

RECRUITINGPhase 4

Responsiveness of Endoscopic Evaluation in UC

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis（UPRISE）

Association Between LRG and Histologic Remission in Ulcerative Colitis

A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis

Superdonor FMT in Patients With Ulcerative Colitis

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Trial snapshot

Condition

Locations shown

For caregivers